Literature DB >> 2659725

Inflammatory properties of recombinant tumor necrosis factor in rabbit skin in vivo.

M Rampart1, W De Smet, W Fiers, A G Herman.   

Abstract

We have investigated the ability of recombinant TNF (mouse and human) to produce acute inflammatory lesions in an established experimental model of inflammation. Upon intradermal injection in rabbit skin, TNF, in amounts as low as 3 x 10(-14) mol/site, was found to be very potent at inducing local neutrophil accumulation and neutrophil-dependent oedema formation, thereby fulfilling two important criteria to be considered as an inflammatory mediator. Our findings further indicate that the pro-inflammatory properties of TNF are probably more related to its immediate stimulatory effects on neutrophils rather than to its slow (protein biosynthesis-dependent effects on endothelial cells. Our data thus show that very low amounts of mouse and human recombinant TNF can initiate an acute inflammatory reaction in vivo in rabbit skin and that TNF is able to evoke two of the four cardinal signs of inflammation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2659725      PMCID: PMC2189351          DOI: 10.1084/jem.169.6.2227

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.

Authors:  J S Pober; M A Gimbrone; L A Lapierre; D L Mendrick; W Fiers; R Rothlein; T A Springer
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

2.  Different pro-inflammatory profiles of interleukin 1 (IL 1) and tumor necrosis factor (TNF) in an in vivo model of inflammation.

Authors:  M Rampart; W Fiers; W de Smet; A G Herman
Journal:  Agents Actions       Date:  1989-01

3.  Control of vascular permeability by polymorphonuclear leukocytes in inflammation.

Authors:  C V Wedmore; T J Williams
Journal:  Nature       Date:  1981-02-19       Impact factor: 49.962

Review 4.  Cachectin and tumour necrosis factor as two sides of the same biological coin.

Authors:  B Beutler; A Cerami
Journal:  Nature       Date:  1986 Apr 17-23       Impact factor: 49.962

5.  Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration.

Authors:  M Rampart; T J Williams
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

6.  Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.

Authors:  J R Gamble; J M Harlan; S J Klebanoff; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

7.  Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: structure-function assessments employing subunit-specific monoclonal antibodies.

Authors:  D C Anderson; L J Miller; F C Schmalstieg; R Rothlein; T A Springer
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

8.  Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines.

Authors:  M P Bevilacqua; J S Pober; M E Wheeler; R S Cotran; M A Gimbrone
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

9.  Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition.

Authors:  C Baglioni; S McCandless; J Tavernier; W Fiers
Journal:  J Biol Chem       Date:  1985-11-05       Impact factor: 5.157

10.  Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor.

Authors:  A Marmenout; L Fransen; J Tavernier; J Van der Heyden; R Tizard; E Kawashima; A Shaw; M J Johnson; D Semon; R Müller
Journal:  Eur J Biochem       Date:  1985-11-04
View more
  21 in total

1.  Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease.

Authors:  J Bauditz; S Wedel; H Lochs
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

2.  Divergent mechanisms of action of the inflammatory cytokines interleukin 1-beta and tumour necrosis factor-alpha in mouse cremasteric venules.

Authors:  R E Young; R D Thompson; S Nourshargh
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

3.  Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation.

Authors:  Kavitha Viswanathan; Firdaus S Dhabhar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-07       Impact factor: 11.205

4.  Induction of inflammatory cell infiltration and necrosis in normal mouse skin by the combined treatment of tumor necrosis factor and lithium chloride.

Authors:  R Beyaert; C De Potter; B Vanhaesebroeck; F Van Roy; W Fiers
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

5.  Endotoxin, interleukin-1, and tumor necrosis factor cause neutrophil-dependent microvascular leakage in postcapillary venules.

Authors:  E S Yi; T R Ulich
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

6.  Effect of soluble P55 tumour-necrosis factor binding fusion protein on the local Shwartzman and Arthus reactions.

Authors:  K E Norman; T J Williams; M Feldmann; A G Rossi
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

7.  Tumour necrosis factor-alpha but not interleukin-1 induces polymorphonuclear leucocyte migration through fibroblast layers by a fibroblast-dependent mechanism.

Authors:  W Morzycki; A C Issekutz
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

8.  Time-dependent synergistic interactions between the vasodilator neuropeptide, calcitonin gene-related peptide (CGRP) and mediators of inflammation.

Authors:  T L Buckley; S D Brain; M Rampart; T J Williams
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

9.  Eosinophil ribonucleases and their cutaneous lesion-forming activity.

Authors:  Douglas A Plager; Mark D P Davis; Amy G Andrews; Michael J Coenen; Terry J George; Gerald J Gleich; Kristin M Leiferman
Journal:  J Immunol       Date:  2009-08-28       Impact factor: 5.422

10.  Mast cell-derived particles deliver peripheral signals to remote lymph nodes.

Authors:  Christian A Kunder; Ashley L St John; Guojie Li; Kam W Leong; Brent Berwin; Herman F Staats; Soman N Abraham
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.